Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
Smith MJ, Gill PG, Wetzig N, Sourjina T, Gebski V, Ung O, Campbell I, Kollias J, Coskinas X, Macphee A, Young L, Simes RJ, Stockler MR; Royal Australasian College of Surgeons SNAC Trial Group. Smith MJ, et al. Among authors: stockler mr. Breast Cancer Res Treat. 2009 Sep;117(1):99-109. doi: 10.1007/s10549-008-0202-3. Epub 2008 Oct 17. Breast Cancer Res Treat. 2009. PMID: 18925434 Clinical Trial.
Hospitalised patients' views on doctors and white coats.
Gooden BR, Smith MJ, Tattersall SJ, Stockler MR. Gooden BR, et al. Among authors: stockler mr. Med J Aust. 2001 Aug 20;175(4):219-22. doi: 10.5694/j.1326-5377.2001.tb143103.x. Med J Aust. 2001. PMID: 11587285
The benefits and costs of tamoxifen for breast cancer prevention.
Eckermann SD, Martin AJ, Stockler MR, Simes RJ. Eckermann SD, et al. Among authors: stockler mr. Aust N Z J Public Health. 2003;27(1):34-40. doi: 10.1111/j.1467-842x.2003.tb00377.x. Aust N Z J Public Health. 2003. PMID: 14705265 Free article.
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.
Cebon J, Findlay M, Hargreaves C, Stockler M, Thompson P, Boyer M, Roberts S, Poon A, Scott AM, Kalff V, Garas G, Dowling A, Crawford D, Ring J, Basser R, Strickland A, Macdonald G, Green M, Nowak A, Dickman B, Dhillon H, Gebski V; Australasian Gastro-Intestinal Trials Group (AGITG) Ag0001H Investigators. Cebon J, et al. Br J Cancer. 2006 Oct 9;95(7):853-61. doi: 10.1038/sj.bjc.6603325. Epub 2006 Sep 5. Br J Cancer. 2006. PMID: 16953241 Free PMC article. Clinical Trial.
305 results